Trial intelligence / Profile preview

Near-infrared fluorescence imaging in kidney transplantations using ZW800-1 for perfusion assessment: a pilot study

2018-000985-12Phase 2Completed

Sponsor
Leiden University Medical Center
Start
Jul 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of nizaracianine triflutate in kidney transplant, sponsored by Leiden University Medical Center. Primary endpoint: Signal-to-background ratio. Started Jul 2018; status: completed.

02

Drugs

nizaracianine triflutate
03

Conditions

kidney transplant

Beyond the preview

Go deeper on 2018-000985-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-000985-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call